← All companies
Regencell Bioscience Holdings Ltd
RGC - CIK 0001829667
Market cap$9.34 B
Rank#983
SEC filings82
The table below shows Regencell Bioscience Holdings Ltd's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $948.29K | $1.07M | $1.58M | $2.51M | $438.32K | $386.23K |
| SG&A | $2.81M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.